Roberto Olivardia Joseph Biederman Ann Childress Usa state Massachusets child research and news for professionals Roberto Olivardia Joseph Biederman Ann Childress Usa state Massachusets

Remembering ADHD Pioneer Joseph Biederman, M.D.

Reading now: 172
www.additudemag.com

January 10, 2023Psychiatrist, ADHD expert, and ADDitude contributor Joseph Biederman, M.D., passed away late last week, just days before he was scheduled to receive a Lifetime Achievement Award from the American Professional Society of ADHD and Related Disorders (APSARD), which he co-founded, honoring his decades of groundbreaking ADHD research and advocacy.Biederman, age 75, served as Chief of the Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD at Massachusetts General Hospital (MGH), Director of the Alan and Lorraine Bressler Clinical and Research Program for Autism Spectrum Disorders at MGH, and Professor of Psychiatry at Harvard Medical School.Considered the father of pediatric psychopharmacology, Biederman dedicated his career to examining the causes, diagnosis, and ADHD treatment across the lifespan.“He was truly a giant in our field with a brilliant mind and compelling personality,” wrote APSARD president Ann Childress, M.D., on the organization’s website. “As one of the most highly cited child and adolescent psychiatrists in the world, he changed the course of pediatric psychopharmacology.

More importantly to us, as his colleagues, he was also a great teacher and mentor, a world-class clinician, a tireless champion of causes he believed in, and a great friend.”“Dr.

Joseph Biederman is a pioneer in the ADHD community,” said Roberto Olivardia, Ph.D., a Clinical Psychologist and Clinical Instructor of Psychology at Harvard Medical School. “So much of what we know about the psychopharmacological treatment of ADHD and other pediatric conditions is because of Dr.

Read more on additudemag.com
The website mental.guide is an aggregator of articles from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the article if you find it unreliable.

Related articles

DMCA